APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 60 filers reported holding APTOSE BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -71.3% | 57,166 | -74.4% | 0.00% | – |
| Q4 2022 | $129 | -99.8% | 222,930 | +75.4% | 0.00% | – |
| Q3 2022 | $76,000 | -29.6% | 127,134 | -12.7% | 0.00% | – |
| Q2 2022 | $108,000 | -89.8% | 145,627 | -81.2% | 0.00% | -100.0% |
| Q1 2022 | $1,054,000 | -28.5% | 775,214 | -29.0% | 0.00% | 0.0% |
| Q4 2021 | $1,474,000 | -2.4% | 1,091,222 | +57.6% | 0.00% | 0.0% |
| Q3 2021 | $1,510,000 | +44.2% | 692,531 | +119.6% | 0.00% | 0.0% |
| Q2 2021 | $1,047,000 | -52.0% | 315,293 | -13.7% | 0.00% | -50.0% |
| Q1 2021 | $2,183,000 | +150.6% | 365,431 | +83.8% | 0.00% | +100.0% |
| Q4 2020 | $871,000 | -16.6% | 198,854 | +14.3% | 0.00% | 0.0% |
| Q3 2020 | $1,044,000 | +0.6% | 174,051 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $1,038,000 | -78.2% | 164,476 | -79.5% | 0.00% | -90.9% |
| Q1 2020 | $4,766,000 | +1.2% | 802,378 | -3.4% | 0.01% | +83.3% |
| Q4 2019 | $4,709,000 | – | 830,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |